+1 (704) 266-3234
+1 (704) 266-3234You are here :
Published on: Jan 2024 | From USD $3660 | Published By: LP INFORMATION INC | Number Of Pages: 117
According to our LPI (LP Information) latest study, the global Transforming Growth Factor Beta 1 market size was valued at US$ 1426.5 million in 2023. With growing demand in downstream market, the Transforming Growth Factor Beta 1 is forecast to a readjusted size of US$ 3059.1 million by 2030 with a CAGR of 11.5% during review period.
The research report highlights the growth potential of the global Transforming Growth Factor Beta 1 market. Transforming Growth Factor Beta 1 are expected to show stable growth in the future market. However, product differentiation, reducing costs, and supply chain optimization remain crucial for the widespread adoption of Transforming Growth Factor Beta 1. Market players need to invest in research and development, forge strategic partnerships, and align their offerings with evolving consumer preferences to capitalize on the immense opportunities presented by the Transforming Growth Factor Beta 1 market.
Transforming growth factor beta 1 or TGF-?1 is a polypeptide member of the transforming growth factor beta superfamily of cytokines. It is a secreted protein that performs many cellular functions, including the control of cell growth, cell proliferation, cell differentiation, and apoptosis. In humans, TGF-?1 is encoded by the TGFB1 gene
North America is the largest Transforming Growth Factor Beta 1 market with about 69% market share. Europe is follower, accounting for about 16% market share.The key manufacturers are Roche, Shionogi Ltd, Acceleron Pharma Inc, Genzyme Corp, Isarna Therapeutics GmbH, Scholar Rock, Sirnaomics Inc, Eli Lilly and Co, Formation Biologics Inc, Novartis AG etc.
Key Features:
The report on Transforming Growth Factor Beta 1 market reflects various aspects and provide valuable insights into the industry.
Market Size and Growth: The research report provide an overview of the current size and growth of the Transforming Growth Factor Beta 1 market. It may include historical data, market segmentation by Type (e.g., Pirfenidone, Galunisertib), and regional breakdowns.
Market Drivers and Challenges: The report can identify and analyse the factors driving the growth of the Transforming Growth Factor Beta 1 market, such as government regulations, environmental concerns, technological advancements, and changing consumer preferences. It can also highlight the challenges faced by the industry, including infrastructure limitations, range anxiety, and high upfront costs.
Competitive Landscape: The research report provides analysis of the competitive landscape within the Transforming Growth Factor Beta 1 market. It includes profiles of key players, their market share, strategies, and product offerings. The report can also highlight emerging players and their potential impact on the market.
Technological Developments: The research report can delve into the latest technological developments in the Transforming Growth Factor Beta 1 industry. This include advancements in Transforming Growth Factor Beta 1 technology, Transforming Growth Factor Beta 1 new entrants, Transforming Growth Factor Beta 1 new investment, and other innovations that are shaping the future of Transforming Growth Factor Beta 1.
Downstream Procumbent Preference: The report can shed light on customer procumbent behaviour and adoption trends in the Transforming Growth Factor Beta 1 market. It includes factors influencing customer ' purchasing decisions, preferences for Transforming Growth Factor Beta 1 product.
Government Policies and Incentives: The research report analyse the impact of government policies and incentives on the Transforming Growth Factor Beta 1 market. This may include an assessment of regulatory frameworks, subsidies, tax incentives, and other measures aimed at promoting Transforming Growth Factor Beta 1 market. The report also evaluates the effectiveness of these policies in driving market growth.
Environmental Impact and Sustainability: The research report assess the environmental impact and sustainability aspects of the Transforming Growth Factor Beta 1 market.
Market Forecasts and Future Outlook: Based on the analysis conducted, the research report provide market forecasts and outlook for the Transforming Growth Factor Beta 1 industry. This includes projections of market size, growth rates, regional trends, and predictions on technological advancements and policy developments.
Recommendations and Opportunities: The report conclude with recommendations for industry stakeholders, policymakers, and investors. It highlights potential opportunities for market players to capitalize on emerging trends, overcome challenges, and contribute to the growth and development of the Transforming Growth Factor Beta 1 market.
Market Segmentation:
Transforming Growth Factor Beta 1 market is split by Type and by Application. For the period 2019-2030, the growth among segments provides accurate calculations and forecasts for consumption value by Type, and by Application in terms of volume and value.
Segmentation by type
Pirfenidone
Galunisertib
Others
Segmentation by application
IPF
Cancer
Others
This report also splits the market by region:
Americas
United States
Canada
Mexico
Brazil
APAC
China
Japan
Korea
Southeast Asia
India
Australia
Europe
Germany
France
UK
Italy
Russia
Middle East & Africa
Egypt
South Africa
Israel
Turkey
GCC Countries
The below companies that are profiled have been selected based on inputs gathered from primary experts and analyzing the company's coverage, product portfolio, its market penetration.
Roche
Shionogi Ltd
Acceleron Pharma Inc
Genzyme Corp
Isarna Therapeutics GmbH
Scholar Rock
Sirnaomics Inc
Eli Lilly and Co
Formation Biologics Inc
Novartis AG
Key Questions Addressed in this Report
What is the 10-year outlook for the global Transforming Growth Factor Beta 1 market?
What factors are driving Transforming Growth Factor Beta 1 market growth, globally and by region?
Which technologies are poised for the fastest growth by market and region?
How do Transforming Growth Factor Beta 1 market opportunities vary by end market size?
How does Transforming Growth Factor Beta 1 break out type, application?
1 Scope of the Report
1.1 Market Introduction
1.2 Years Considered
1.3 Research Objectives
1.4 Market Research Methodology
1.5 Research Process and Data Source
1.6 Economic Indicators
1.7 Currency Considered
1.8 Market Estimation Caveats
2 Executive Summary
2.1 World Market Overview
2.1.1 Global Transforming Growth Factor Beta 1 Annual Sales 2019-2030
2.1.2 World Current & Future Analysis for Transforming Growth Factor Beta 1 by Geographic Region, 2019, 2023 & 2030
2.1.3 World Current & Future Analysis for Transforming Growth Factor Beta 1 by Country/Region, 2019, 2023 & 2030
2.2 Transforming Growth Factor Beta 1 Segment by Type
2.2.1 Pirfenidone
2.2.2 Galunisertib
2.2.3 Others
2.3 Transforming Growth Factor Beta 1 Sales by Type
2.3.1 Global Transforming Growth Factor Beta 1 Sales Market Share by Type (2019-2024)
2.3.2 Global Transforming Growth Factor Beta 1 Revenue and Market Share by Type (2019-2024)
2.3.3 Global Transforming Growth Factor Beta 1 Sale Price by Type (2019-2024)
2.4 Transforming Growth Factor Beta 1 Segment by Application
2.4.1 IPF
2.4.2 Cancer
2.4.3 Others
2.5 Transforming Growth Factor Beta 1 Sales by Application
2.5.1 Global Transforming Growth Factor Beta 1 Sale Market Share by Application (2019-2024)
2.5.2 Global Transforming Growth Factor Beta 1 Revenue and Market Share by Application (2019-2024)
2.5.3 Global Transforming Growth Factor Beta 1 Sale Price by Application (2019-2024)
3 Global Transforming Growth Factor Beta 1 by Company
3.1 Global Transforming Growth Factor Beta 1 Breakdown Data by Company
3.1.1 Global Transforming Growth Factor Beta 1 Annual Sales by Company (2019-2024)
3.1.2 Global Transforming Growth Factor Beta 1 Sales Market Share by Company (2019-2024)
3.2 Global Transforming Growth Factor Beta 1 Annual Revenue by Company (2019-2024)
3.2.1 Global Transforming Growth Factor Beta 1 Revenue by Company (2019-2024)
3.2.2 Global Transforming Growth Factor Beta 1 Revenue Market Share by Company (2019-2024)
3.3 Global Transforming Growth Factor Beta 1 Sale Price by Company
3.4 Key Manufacturers Transforming Growth Factor Beta 1 Producing Area Distribution, Sales Area, Product Type
3.4.1 Key Manufacturers Transforming Growth Factor Beta 1 Product Location Distribution
3.4.2 Players Transforming Growth Factor Beta 1 Products Offered
3.5 Market Concentration Rate Analysis
3.5.1 Competition Landscape Analysis
3.5.2 Concentration Ratio (CR3, CR5 and CR10) & (2019-2024)
3.6 New Products and Potential Entrants
3.7 Mergers & Acquisitions, Expansion
4 World Historic Review for Transforming Growth Factor Beta 1 by Geographic Region
4.1 World Historic Transforming Growth Factor Beta 1 Market Size by Geographic Region (2019-2024)
4.1.1 Global Transforming Growth Factor Beta 1 Annual Sales by Geographic Region (2019-2024)
4.1.2 Global Transforming Growth Factor Beta 1 Annual Revenue by Geographic Region (2019-2024)
4.2 World Historic Transforming Growth Factor Beta 1 Market Size by Country/Region (2019-2024)
4.2.1 Global Transforming Growth Factor Beta 1 Annual Sales by Country/Region (2019-2024)
4.2.2 Global Transforming Growth Factor Beta 1 Annual Revenue by Country/Region (2019-2024)
4.3 Americas Transforming Growth Factor Beta 1 Sales Growth
4.4 APAC Transforming Growth Factor Beta 1 Sales Growth
4.5 Europe Transforming Growth Factor Beta 1 Sales Growth
4.6 Middle East & Africa Transforming Growth Factor Beta 1 Sales Growth
5 Americas
5.1 Americas Transforming Growth Factor Beta 1 Sales by Country
5.1.1 Americas Transforming Growth Factor Beta 1 Sales by Country (2019-2024)
5.1.2 Americas Transforming Growth Factor Beta 1 Revenue by Country (2019-2024)
5.2 Americas Transforming Growth Factor Beta 1 Sales by Type
5.3 Americas Transforming Growth Factor Beta 1 Sales by Application
5.4 United States
5.5 Canada
5.6 Mexico
5.7 Brazil
6 APAC
6.1 APAC Transforming Growth Factor Beta 1 Sales by Region
6.1.1 APAC Transforming Growth Factor Beta 1 Sales by Region (2019-2024)
6.1.2 APAC Transforming Growth Factor Beta 1 Revenue by Region (2019-2024)
6.2 APAC Transforming Growth Factor Beta 1 Sales by Type
6.3 APAC Transforming Growth Factor Beta 1 Sales by Application
6.4 China
6.5 Japan
6.6 South Korea
6.7 Southeast Asia
6.8 India
6.9 Australia
6.10 China Taiwan
7 Europe
7.1 Europe Transforming Growth Factor Beta 1 by Country
7.1.1 Europe Transforming Growth Factor Beta 1 Sales by Country (2019-2024)
7.1.2 Europe Transforming Growth Factor Beta 1 Revenue by Country (2019-2024)
7.2 Europe Transforming Growth Factor Beta 1 Sales by Type
7.3 Europe Transforming Growth Factor Beta 1 Sales by Application
7.4 Germany
7.5 France
7.6 UK
7.7 Italy
7.8 Russia
8 Middle East & Africa
8.1 Middle East & Africa Transforming Growth Factor Beta 1 by Country
8.1.1 Middle East & Africa Transforming Growth Factor Beta 1 Sales by Country (2019-2024)
8.1.2 Middle East & Africa Transforming Growth Factor Beta 1 Revenue by Country (2019-2024)
8.2 Middle East & Africa Transforming Growth Factor Beta 1 Sales by Type
8.3 Middle East & Africa Transforming Growth Factor Beta 1 Sales by Application
8.4 Egypt
8.5 South Africa
8.6 Israel
8.7 Turkey
8.8 GCC Countries
9 Market Drivers, Challenges and Trends
9.1 Market Drivers & Growth Opportunities
9.2 Market Challenges & Risks
9.3 Industry Trends
10 Manufacturing Cost Structure Analysis
10.1 Raw Material and Suppliers
10.2 Manufacturing Cost Structure Analysis of Transforming Growth Factor Beta 1
10.3 Manufacturing Process Analysis of Transforming Growth Factor Beta 1
10.4 Industry Chain Structure of Transforming Growth Factor Beta 1
11 Marketing, Distributors and Customer
11.1 Sales Channel
11.1.1 Direct Channels
11.1.2 Indirect Channels
11.2 Transforming Growth Factor Beta 1 Distributors
11.3 Transforming Growth Factor Beta 1 Customer
12 World Forecast Review for Transforming Growth Factor Beta 1 by Geographic Region
12.1 Global Transforming Growth Factor Beta 1 Market Size Forecast by Region
12.1.1 Global Transforming Growth Factor Beta 1 Forecast by Region (2025-2030)
12.1.2 Global Transforming Growth Factor Beta 1 Annual Revenue Forecast by Region (2025-2030)
12.2 Americas Forecast by Country
12.3 APAC Forecast by Region
12.4 Europe Forecast by Country
12.5 Middle East & Africa Forecast by Country
12.6 Global Transforming Growth Factor Beta 1 Forecast by Type
12.7 Global Transforming Growth Factor Beta 1 Forecast by Application
13 Key Players Analysis
13.1 Roche
13.1.1 Roche Company Information
13.1.2 Roche Transforming Growth Factor Beta 1 Product Portfolios and Specifications
13.1.3 Roche Transforming Growth Factor Beta 1 Sales, Revenue, Price and Gross Margin (2019-2024)
13.1.4 Roche Main Business Overview
13.1.5 Roche Latest Developments
13.2 Shionogi Ltd
13.2.1 Shionogi Ltd Company Information
13.2.2 Shionogi Ltd Transforming Growth Factor Beta 1 Product Portfolios and Specifications
13.2.3 Shionogi Ltd Transforming Growth Factor Beta 1 Sales, Revenue, Price and Gross Margin (2019-2024)
13.2.4 Shionogi Ltd Main Business Overview
13.2.5 Shionogi Ltd Latest Developments
13.3 Acceleron Pharma Inc
13.3.1 Acceleron Pharma Inc Company Information
13.3.2 Acceleron Pharma Inc Transforming Growth Factor Beta 1 Product Portfolios and Specifications
13.3.3 Acceleron Pharma Inc Transforming Growth Factor Beta 1 Sales, Revenue, Price and Gross Margin (2019-2024)
13.3.4 Acceleron Pharma Inc Main Business Overview
13.3.5 Acceleron Pharma Inc Latest Developments
13.4 Genzyme Corp
13.4.1 Genzyme Corp Company Information
13.4.2 Genzyme Corp Transforming Growth Factor Beta 1 Product Portfolios and Specifications
13.4.3 Genzyme Corp Transforming Growth Factor Beta 1 Sales, Revenue, Price and Gross Margin (2019-2024)
13.4.4 Genzyme Corp Main Business Overview
13.4.5 Genzyme Corp Latest Developments
13.5 Isarna Therapeutics GmbH
13.5.1 Isarna Therapeutics GmbH Company Information
13.5.2 Isarna Therapeutics GmbH Transforming Growth Factor Beta 1 Product Portfolios and Specifications
13.5.3 Isarna Therapeutics GmbH Transforming Growth Factor Beta 1 Sales, Revenue, Price and Gross Margin (2019-2024)
13.5.4 Isarna Therapeutics GmbH Main Business Overview
13.5.5 Isarna Therapeutics GmbH Latest Developments
13.6 Scholar Rock
13.6.1 Scholar Rock Company Information
13.6.2 Scholar Rock Transforming Growth Factor Beta 1 Product Portfolios and Specifications
13.6.3 Scholar Rock Transforming Growth Factor Beta 1 Sales, Revenue, Price and Gross Margin (2019-2024)
13.6.4 Scholar Rock Main Business Overview
13.6.5 Scholar Rock Latest Developments
13.7 Sirnaomics Inc
13.7.1 Sirnaomics Inc Company Information
13.7.2 Sirnaomics Inc Transforming Growth Factor Beta 1 Product Portfolios and Specifications
13.7.3 Sirnaomics Inc Transforming Growth Factor Beta 1 Sales, Revenue, Price and Gross Margin (2019-2024)
13.7.4 Sirnaomics Inc Main Business Overview
13.7.5 Sirnaomics Inc Latest Developments
13.8 Eli Lilly and Co
13.8.1 Eli Lilly and Co Company Information
13.8.2 Eli Lilly and Co Transforming Growth Factor Beta 1 Product Portfolios and Specifications
13.8.3 Eli Lilly and Co Transforming Growth Factor Beta 1 Sales, Revenue, Price and Gross Margin (2019-2024)
13.8.4 Eli Lilly and Co Main Business Overview
13.8.5 Eli Lilly and Co Latest Developments
13.9 Formation Biologics Inc
13.9.1 Formation Biologics Inc Company Information
13.9.2 Formation Biologics Inc Transforming Growth Factor Beta 1 Product Portfolios and Specifications
13.9.3 Formation Biologics Inc Transforming Growth Factor Beta 1 Sales, Revenue, Price and Gross Margin (2019-2024)
13.9.4 Formation Biologics Inc Main Business Overview
13.9.5 Formation Biologics Inc Latest Developments
13.10 Novartis AG
13.10.1 Novartis AG Company Information
13.10.2 Novartis AG Transforming Growth Factor Beta 1 Product Portfolios and Specifications
13.10.3 Novartis AG Transforming Growth Factor Beta 1 Sales, Revenue, Price and Gross Margin (2019-2024)
13.10.4 Novartis AG Main Business Overview
13.10.5 Novartis AG Latest Developments
14 Research Findings and Conclusion
List of Tables
Table 1. Transforming Growth Factor Beta 1 Annual Sales CAGR by Geographic Region (2019, 2023 & 2030) & ($ millions)
Table 2. Transforming Growth Factor Beta 1 Annual Sales CAGR by Country/Region (2019, 2023 & 2030) & ($ millions)
Table 3. Major Players of Pirfenidone
Table 4. Major Players of Galunisertib
Table 5. Major Players of Others
Table 6. Global Transforming Growth Factor Beta 1 Sales by Type (2019-2024) & (K Units)
Table 7. Global Transforming Growth Factor Beta 1 Sales Market Share by Type (2019-2024)
Table 8. Global Transforming Growth Factor Beta 1 Revenue by Type (2019-2024) & ($ million)
Table 9. Global Transforming Growth Factor Beta 1 Revenue Market Share by Type (2019-2024)
Table 10. Global Transforming Growth Factor Beta 1 Sale Price by Type (2019-2024) & (USD/Unit)
Table 11. Global Transforming Growth Factor Beta 1 Sales by Application (2019-2024) & (K Units)
Table 12. Global Transforming Growth Factor Beta 1 Sales Market Share by Application (2019-2024)
Table 13. Global Transforming Growth Factor Beta 1 Revenue by Application (2019-2024)
Table 14. Global Transforming Growth Factor Beta 1 Revenue Market Share by Application (2019-2024)
Table 15. Global Transforming Growth Factor Beta 1 Sale Price by Application (2019-2024) & (USD/Unit)
Table 16. Global Transforming Growth Factor Beta 1 Sales by Company (2019-2024) & (K Units)
Table 17. Global Transforming Growth Factor Beta 1 Sales Market Share by Company (2019-2024)
Table 18. Global Transforming Growth Factor Beta 1 Revenue by Company (2019-2024) ($ Millions)
Table 19. Global Transforming Growth Factor Beta 1 Revenue Market Share by Company (2019-2024)
Table 20. Global Transforming Growth Factor Beta 1 Sale Price by Company (2019-2024) & (USD/Unit)
Table 21. Key Manufacturers Transforming Growth Factor Beta 1 Producing Area Distribution and Sales Area
Table 22. Players Transforming Growth Factor Beta 1 Products Offered
Table 23. Transforming Growth Factor Beta 1 Concentration Ratio (CR3, CR5 and CR10) & (2019-2024)
Table 24. New Products and Potential Entrants
Table 25. Mergers & Acquisitions, Expansion
Table 26. Global Transforming Growth Factor Beta 1 Sales by Geographic Region (2019-2024) & (K Units)
Table 27. Global Transforming Growth Factor Beta 1 Sales Market Share Geographic Region (2019-2024)
Table 28. Global Transforming Growth Factor Beta 1 Revenue by Geographic Region (2019-2024) & ($ millions)
Table 29. Global Transforming Growth Factor Beta 1 Revenue Market Share by Geographic Region (2019-2024)
Table 30. Global Transforming Growth Factor Beta 1 Sales by Country/Region (2019-2024) & (K Units)
Table 31. Global Transforming Growth Factor Beta 1 Sales Market Share by Country/Region (2019-2024)
Table 32. Global Transforming Growth Factor Beta 1 Revenue by Country/Region (2019-2024) & ($ millions)
Table 33. Global Transforming Growth Factor Beta 1 Revenue Market Share by Country/Region (2019-2024)
Table 34. Americas Transforming Growth Factor Beta 1 Sales by Country (2019-2024) & (K Units)
Table 35. Americas Transforming Growth Factor Beta 1 Sales Market Share by Country (2019-2024)
Table 36. Americas Transforming Growth Factor Beta 1 Revenue by Country (2019-2024) & ($ Millions)
Table 37. Americas Transforming Growth Factor Beta 1 Revenue Market Share by Country (2019-2024)
Table 38. Americas Transforming Growth Factor Beta 1 Sales by Type (2019-2024) & (K Units)
Table 39. Americas Transforming Growth Factor Beta 1 Sales by Application (2019-2024) & (K Units)
Table 40. APAC Transforming Growth Factor Beta 1 Sales by Region (2019-2024) & (K Units)
Table 41. APAC Transforming Growth Factor Beta 1 Sales Market Share by Region (2019-2024)
Table 42. APAC Transforming Growth Factor Beta 1 Revenue by Region (2019-2024) & ($ Millions)
Table 43. APAC Transforming Growth Factor Beta 1 Revenue Market Share by Region (2019-2024)
Table 44. APAC Transforming Growth Factor Beta 1 Sales by Type (2019-2024) & (K Units)
Table 45. APAC Transforming Growth Factor Beta 1 Sales by Application (2019-2024) & (K Units)
Table 46. Europe Transforming Growth Factor Beta 1 Sales by Country (2019-2024) & (K Units)
Table 47. Europe Transforming Growth Factor Beta 1 Sales Market Share by Country (2019-2024)
Table 48. Europe Transforming Growth Factor Beta 1 Revenue by Country (2019-2024) & ($ Millions)
Table 49. Europe Transforming Growth Factor Beta 1 Revenue Market Share by Country (2019-2024)
Table 50. Europe Transforming Growth Factor Beta 1 Sales by Type (2019-2024) & (K Units)
Table 51. Europe Transforming Growth Factor Beta 1 Sales by Application (2019-2024) & (K Units)
Table 52. Middle East & Africa Transforming Growth Factor Beta 1 Sales by Country (2019-2024) & (K Units)
Table 53. Middle East & Africa Transforming Growth Factor Beta 1 Sales Market Share by Country (2019-2024)
Table 54. Middle East & Africa Transforming Growth Factor Beta 1 Revenue by Country (2019-2024) & ($ Millions)
Table 55. Middle East & Africa Transforming Growth Factor Beta 1 Revenue Market Share by Country (2019-2024)
Table 56. Middle East & Africa Transforming Growth Factor Beta 1 Sales by Type (2019-2024) & (K Units)
Table 57. Middle East & Africa Transforming Growth Factor Beta 1 Sales by Application (2019-2024) & (K Units)
Table 58. Key Market Drivers & Growth Opportunities of Transforming Growth Factor Beta 1
Table 59. Key Market Challenges & Risks of Transforming Growth Factor Beta 1
Table 60. Key Industry Trends of Transforming Growth Factor Beta 1
Table 61. Transforming Growth Factor Beta 1 Raw Material
Table 62. Key Suppliers of Raw Materials
Table 63. Transforming Growth Factor Beta 1 Distributors List
Table 64. Transforming Growth Factor Beta 1 Customer List
Table 65. Global Transforming Growth Factor Beta 1 Sales Forecast by Region (2025-2030) & (K Units)
Table 66. Global Transforming Growth Factor Beta 1 Revenue Forecast by Region (2025-2030) & ($ millions)
Table 67. Americas Transforming Growth Factor Beta 1 Sales Forecast by Country (2025-2030) & (K Units)
Table 68. Americas Transforming Growth Factor Beta 1 Revenue Forecast by Country (2025-2030) & ($ millions)
Table 69. APAC Transforming Growth Factor Beta 1 Sales Forecast by Region (2025-2030) & (K Units)
Table 70. APAC Transforming Growth Factor Beta 1 Revenue Forecast by Region (2025-2030) & ($ millions)
Table 71. Europe Transforming Growth Factor Beta 1 Sales Forecast by Country (2025-2030) & (K Units)
Table 72. Europe Transforming Growth Factor Beta 1 Revenue Forecast by Country (2025-2030) & ($ millions)
Table 73. Middle East & Africa Transforming Growth Factor Beta 1 Sales Forecast by Country (2025-2030) & (K Units)
Table 74. Middle East & Africa Transforming Growth Factor Beta 1 Revenue Forecast by Country (2025-2030) & ($ millions)
Table 75. Global Transforming Growth Factor Beta 1 Sales Forecast by Type (2025-2030) & (K Units)
Table 76. Global Transforming Growth Factor Beta 1 Revenue Forecast by Type (2025-2030) & ($ Millions)
Table 77. Global Transforming Growth Factor Beta 1 Sales Forecast by Application (2025-2030) & (K Units)
Table 78. Global Transforming Growth Factor Beta 1 Revenue Forecast by Application (2025-2030) & ($ Millions)
Table 79. Roche Basic Information, Transforming Growth Factor Beta 1 Manufacturing Base, Sales Area and Its Competitors
Table 80. Roche Transforming Growth Factor Beta 1 Product Portfolios and Specifications
Table 81. Roche Transforming Growth Factor Beta 1 Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2019-2024)
Table 82. Roche Main Business
Table 83. Roche Latest Developments
Table 84. Shionogi Ltd Basic Information, Transforming Growth Factor Beta 1 Manufacturing Base, Sales Area and Its Competitors
Table 85. Shionogi Ltd Transforming Growth Factor Beta 1 Product Portfolios and Specifications
Table 86. Shionogi Ltd Transforming Growth Factor Beta 1 Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2019-2024)
Table 87. Shionogi Ltd Main Business
Table 88. Shionogi Ltd Latest Developments
Table 89. Acceleron Pharma Inc Basic Information, Transforming Growth Factor Beta 1 Manufacturing Base, Sales Area and Its Competitors
Table 90. Acceleron Pharma Inc Transforming Growth Factor Beta 1 Product Portfolios and Specifications
Table 91. Acceleron Pharma Inc Transforming Growth Factor Beta 1 Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2019-2024)
Table 92. Acceleron Pharma Inc Main Business
Table 93. Acceleron Pharma Inc Latest Developments
Table 94. Genzyme Corp Basic Information, Transforming Growth Factor Beta 1 Manufacturing Base, Sales Area and Its Competitors
Table 95. Genzyme Corp Transforming Growth Factor Beta 1 Product Portfolios and Specifications
Table 96. Genzyme Corp Transforming Growth Factor Beta 1 Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2019-2024)
Table 97. Genzyme Corp Main Business
Table 98. Genzyme Corp Latest Developments
Table 99. Isarna Therapeutics GmbH Basic Information, Transforming Growth Factor Beta 1 Manufacturing Base, Sales Area and Its Competitors
Table 100. Isarna Therapeutics GmbH Transforming Growth Factor Beta 1 Product Portfolios and Specifications
Table 101. Isarna Therapeutics GmbH Transforming Growth Factor Beta 1 Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2019-2024)
Table 102. Isarna Therapeutics GmbH Main Business
Table 103. Isarna Therapeutics GmbH Latest Developments
Table 104. Scholar Rock Basic Information, Transforming Growth Factor Beta 1 Manufacturing Base, Sales Area and Its Competitors
Table 105. Scholar Rock Transforming Growth Factor Beta 1 Product Portfolios and Specifications
Table 106. Scholar Rock Transforming Growth Factor Beta 1 Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2019-2024)
Table 107. Scholar Rock Main Business
Table 108. Scholar Rock Latest Developments
Table 109. Sirnaomics Inc Basic Information, Transforming Growth Factor Beta 1 Manufacturing Base, Sales Area and Its Competitors
Table 110. Sirnaomics Inc Transforming Growth Factor Beta 1 Product Portfolios and Specifications
Table 111. Sirnaomics Inc Transforming Growth Factor Beta 1 Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2019-2024)
Table 112. Sirnaomics Inc Main Business
Table 113. Sirnaomics Inc Latest Developments
Table 114. Eli Lilly and Co Basic Information, Transforming Growth Factor Beta 1 Manufacturing Base, Sales Area and Its Competitors
Table 115. Eli Lilly and Co Transforming Growth Factor Beta 1 Product Portfolios and Specifications
Table 116. Eli Lilly and Co Transforming Growth Factor Beta 1 Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2019-2024)
Table 117. Eli Lilly and Co Main Business
Table 118. Eli Lilly and Co Latest Developments
Table 119. Formation Biologics Inc Basic Information, Transforming Growth Factor Beta 1 Manufacturing Base, Sales Area and Its Competitors
Table 120. Formation Biologics Inc Transforming Growth Factor Beta 1 Product Portfolios and Specifications
Table 121. Formation Biologics Inc Transforming Growth Factor Beta 1 Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2019-2024)
Table 122. Formation Biologics Inc Main Business
Table 123. Formation Biologics Inc Latest Developments
Table 124. Novartis AG Basic Information, Transforming Growth Factor Beta 1 Manufacturing Base, Sales Area and Its Competitors
Table 125. Novartis AG Transforming Growth Factor Beta 1 Product Portfolios and Specifications
Table 126. Novartis AG Transforming Growth Factor Beta 1 Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2019-2024)
Table 127. Novartis AG Main Business
Table 128. Novartis AG Latest Developments
List of Figures
Figure 1. Picture of Transforming Growth Factor Beta 1
Figure 2. Transforming Growth Factor Beta 1 Report Years Considered
Figure 3. Research Objectives
Figure 4. Research Methodology
Figure 5. Research Process and Data Source
Figure 6. Global Transforming Growth Factor Beta 1 Sales Growth Rate 2019-2030 (K Units)
Figure 7. Global Transforming Growth Factor Beta 1 Revenue Growth Rate 2019-2030 ($ Millions)
Figure 8. Transforming Growth Factor Beta 1 Sales by Region (2019, 2023 & 2030) & ($ Millions)
Figure 9. Product Picture of Pirfenidone
Figure 10. Product Picture of Galunisertib
Figure 11. Product Picture of Others
Figure 12. Global Transforming Growth Factor Beta 1 Sales Market Share by Type in 2023
Figure 13. Global Transforming Growth Factor Beta 1 Revenue Market Share by Type (2019-2024)
Figure 14. Transforming Growth Factor Beta 1 Consumed in IPF
Figure 15. Global Transforming Growth Factor Beta 1 Market: IPF (2019-2024) & (K Units)
Figure 16. Transforming Growth Factor Beta 1 Consumed in Cancer
Figure 17. Global Transforming Growth Factor Beta 1 Market: Cancer (2019-2024) & (K Units)
Figure 18. Transforming Growth Factor Beta 1 Consumed in Others
Figure 19. Global Transforming Growth Factor Beta 1 Market: Others (2019-2024) & (K Units)
Figure 20. Global Transforming Growth Factor Beta 1 Sales Market Share by Application (2023)
Figure 21. Global Transforming Growth Factor Beta 1 Revenue Market Share by Application in 2023
Figure 22. Transforming Growth Factor Beta 1 Sales Market by Company in 2023 (K Units)
Figure 23. Global Transforming Growth Factor Beta 1 Sales Market Share by Company in 2023
Figure 24. Transforming Growth Factor Beta 1 Revenue Market by Company in 2023 ($ Million)
Figure 25. Global Transforming Growth Factor Beta 1 Revenue Market Share by Company in 2023
Figure 26. Global Transforming Growth Factor Beta 1 Sales Market Share by Geographic Region (2019-2024)
Figure 27. Global Transforming Growth Factor Beta 1 Revenue Market Share by Geographic Region in 2023
Figure 28. Americas Transforming Growth Factor Beta 1 Sales 2019-2024 (K Units)
Figure 29. Americas Transforming Growth Factor Beta 1 Revenue 2019-2024 ($ Millions)
Figure 30. APAC Transforming Growth Factor Beta 1 Sales 2019-2024 (K Units)
Figure 31. APAC Transforming Growth Factor Beta 1 Revenue 2019-2024 ($ Millions)
Figure 32. Europe Transforming Growth Factor Beta 1 Sales 2019-2024 (K Units)
Figure 33. Europe Transforming Growth Factor Beta 1 Revenue 2019-2024 ($ Millions)
Figure 34. Middle East & Africa Transforming Growth Factor Beta 1 Sales 2019-2024 (K Units)
Figure 35. Middle East & Africa Transforming Growth Factor Beta 1 Revenue 2019-2024 ($ Millions)
Figure 36. Americas Transforming Growth Factor Beta 1 Sales Market Share by Country in 2023
Figure 37. Americas Transforming Growth Factor Beta 1 Revenue Market Share by Country in 2023
Figure 38. Americas Transforming Growth Factor Beta 1 Sales Market Share by Type (2019-2024)
Figure 39. Americas Transforming Growth Factor Beta 1 Sales Market Share by Application (2019-2024)
Figure 40. United States Transforming Growth Factor Beta 1 Revenue Growth 2019-2024 ($ Millions)
Figure 41. Canada Transforming Growth Factor Beta 1 Revenue Growth 2019-2024 ($ Millions)
Figure 42. Mexico Transforming Growth Factor Beta 1 Revenue Growth 2019-2024 ($ Millions)
Figure 43. Brazil Transforming Growth Factor Beta 1 Revenue Growth 2019-2024 ($ Millions)
Figure 44. APAC Transforming Growth Factor Beta 1 Sales Market Share by Region in 2023
Figure 45. APAC Transforming Growth Factor Beta 1 Revenue Market Share by Regions in 2023
Figure 46. APAC Transforming Growth Factor Beta 1 Sales Market Share by Type (2019-2024)
Figure 47. APAC Transforming Growth Factor Beta 1 Sales Market Share by Application (2019-2024)
Figure 48. China Transforming Growth Factor Beta 1 Revenue Growth 2019-2024 ($ Millions)
Figure 49. Japan Transforming Growth Factor Beta 1 Revenue Growth 2019-2024 ($ Millions)
Figure 50. South Korea Transforming Growth Factor Beta 1 Revenue Growth 2019-2024 ($ Millions)
Figure 51. Southeast Asia Transforming Growth Factor Beta 1 Revenue Growth 2019-2024 ($ Millions)
Figure 52. India Transforming Growth Factor Beta 1 Revenue Growth 2019-2024 ($ Millions)
Figure 53. Australia Transforming Growth Factor Beta 1 Revenue Growth 2019-2024 ($ Millions)
Figure 54. China Taiwan Transforming Growth Factor Beta 1 Revenue Growth 2019-2024 ($ Millions)
Figure 55. Europe Transforming Growth Factor Beta 1 Sales Market Share by Country in 2023
Figure 56. Europe Transforming Growth Factor Beta 1 Revenue Market Share by Country in 2023
Figure 57. Europe Transforming Growth Factor Beta 1 Sales Market Share by Type (2019-2024)
Figure 58. Europe Transforming Growth Factor Beta 1 Sales Market Share by Application (2019-2024)
Figure 59. Germany Transforming Growth Factor Beta 1 Revenue Growth 2019-2024 ($ Millions)
Figure 60. France Transforming Growth Factor Beta 1 Revenue Growth 2019-2024 ($ Millions)
Figure 61. UK Transforming Growth Factor Beta 1 Revenue Growth 2019-2024 ($ Millions)
Figure 62. Italy Transforming Growth Factor Beta 1 Revenue Growth 2019-2024 ($ Millions)
Figure 63. Russia Transforming Growth Factor Beta 1 Revenue Growth 2019-2024 ($ Millions)
Figure 64. Middle East & Africa Transforming Growth Factor Beta 1 Sales Market Share by Country in 2023
Figure 65. Middle East & Africa Transforming Growth Factor Beta 1 Revenue Market Share by Country in 2023
Figure 66. Middle East & Africa Transforming Growth Factor Beta 1 Sales Market Share by Type (2019-2024)
Figure 67. Middle East & Africa Transforming Growth Factor Beta 1 Sales Market Share by Application (2019-2024)
Figure 68. Egypt Transforming Growth Factor Beta 1 Revenue Growth 2019-2024 ($ Millions)
Figure 69. South Africa Transforming Growth Factor Beta 1 Revenue Growth 2019-2024 ($ Millions)
Figure 70. Israel Transforming Growth Factor Beta 1 Revenue Growth 2019-2024 ($ Millions)
Figure 71. Turkey Transforming Growth Factor Beta 1 Revenue Growth 2019-2024 ($ Millions)
Figure 72. GCC Country Transforming Growth Factor Beta 1 Revenue Growth 2019-2024 ($ Millions)
Figure 73. Manufacturing Cost Structure Analysis of Transforming Growth Factor Beta 1 in 2023
Figure 74. Manufacturing Process Analysis of Transforming Growth Factor Beta 1
Figure 75. Industry Chain Structure of Transforming Growth Factor Beta 1
Figure 76. Channels of Distribution
Figure 77. Global Transforming Growth Factor Beta 1 Sales Market Forecast by Region (2025-2030)
Figure 78. Global Transforming Growth Factor Beta 1 Revenue Market Share Forecast by Region (2025-2030)
Figure 79. Global Transforming Growth Factor Beta 1 Sales Market Share Forecast by Type (2025-2030)
Figure 80. Global Transforming Growth Factor Beta 1 Revenue Market Share Forecast by Type (2025-2030)
Figure 81. Global Transforming Growth Factor Beta 1 Sales Market Share Forecast by Application (2025-2030)
Figure 82. Global Transforming Growth Factor Beta 1 Revenue Market Share Forecast by Application (2025-2030)
SECONDARY RESEARCH
Secondary Research Information is collected from a number of publicly available as well as paid databases. Public sources involve publications by different associations and governments, annual reports and statements of companies, white papers and research publications by recognized industry experts and renowned academia etc. Paid data sources include third party authentic industry databases.
PRIMARY RESEARCH
Once data collection is done through secondary research, primary interviews are conducted with different stakeholders across the value chain like manufacturers, distributors, ingredient/input suppliers, end customers and other key opinion leaders of the industry. Primary research is used both to validate the data points obtained from secondary research and to fill in the data gaps after secondary research.
MARKET ENGINEERING
The market engineering phase involves analyzing the data collected, market breakdown and forecasting. Macroeconomic indicators and bottom-up and top-down approaches are used to arrive at a complete set of data points that give way to valuable qualitative and quantitative insights. Each data point is verified by the process of data triangulation to validate the numbers and arrive at close estimates.
EXPERT VALIDATION
The market engineered data is verified and validated by a number of experts, both in-house and external.
REPORT WRITING/ PRESENTATION
After the data is curated by the mentioned highly sophisticated process, the analysts begin to write the report. Garnering insights from data and forecasts, insights are drawn to visualize the entire ecosystem in a single report.
In-depth database
Our Report’s database covers almost all topics of all regions over the Globe..
Recognised publishing sources
Tie ups with top publishers around the globe.
Customer Support
Complete pre and post sales support.
Safe & Secure
Complete secure payment process.
: sales@marketintelligencedata.com
: 1137 waynewood dr,Waxhaw NC 28173 ,United States
: +1 (704) 266-3234
